Tech Company Financing Transactions

Iterative Health Funding Round

On 1/27/2022, Iterative Health received $150 million in Series B financing from Clearlake Capital Group, Insight Venture Partners and Breyer Capital.

Transaction Overview

Company Name
Iterative Health
Announced On
1/27/2022
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series B
Investors

Clearlake Capital Group (Lead Investor) (Paul Huber)

Insight Venture Partners (Lead Investor) (Lonne Jaffe)

Breyer Capital

Eli Lilly and Company (Lotus Mallbris)

Johnson & Johnson Development Corporation

Obvious Ventures (Nan Li)

Proceeds Purpose
The new funding will allow Iterative Scopes to speed up development of AI technology products and services by scaling the company's technical and clinical operations teams.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
675 Massachusetts Ave 8th Floor
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
www.iterative.health
Email Address
[email protected]
Overview
Our mission is to accelerate clinical research to bring life-changing therapies to patients sooner, transforming care through expertise and proven results. Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. Today, Iterative Health is based in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.
Profile
Iterative Health LinkedIn Company Profile
Social Media
Iterative Health Company Twitter Account
Company News
Iterative Health News
Facebook
Iterative Health on Facebook
YouTube
Iterative Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Ng
  Jonathan Ng LinkedIn Profile  Jonathan Ng Twitter Account  Jonathan Ng News  Jonathan Ng on Facebook
Chief Financial Officer
Bill Kayser
  Bill Kayser LinkedIn Profile  Bill Kayser Twitter Account  Bill Kayser News  Bill Kayser on Facebook
Chief Medical Officer
Nadege Gunn
  Nadege Gunn LinkedIn Profile  Nadege Gunn Twitter Account  Nadege Gunn News  Nadege Gunn on Facebook
Chief Operating Officer
Dana Feuchtbaum
  Dana Feuchtbaum LinkedIn Profile  Dana Feuchtbaum Twitter Account  Dana Feuchtbaum News  Dana Feuchtbaum on Facebook
Vice President
Constantin Claussen
  Constantin Claussen LinkedIn Profile  Constantin Claussen Twitter Account  Constantin Claussen News  Constantin Claussen on Facebook
Vice President
Mark Molenda
  Mark Molenda LinkedIn Profile  Mark Molenda Twitter Account  Mark Molenda News  Mark Molenda on Facebook
Vice President
Charles Owen
  Charles Owen LinkedIn Profile  Charles Owen Twitter Account  Charles Owen News  Charles Owen on Facebook
VP - Administration
Christina Wyrwik
  Christina Wyrwik LinkedIn Profile  Christina Wyrwik Twitter Account  Christina Wyrwik News  Christina Wyrwik on Facebook
VP - Bus. Development
Julie Chang
  Julie Chang LinkedIn Profile  Julie Chang Twitter Account  Julie Chang News  Julie Chang on Facebook
VP - Bus. Development
Matt Morris
  Matt Morris LinkedIn Profile  Matt Morris Twitter Account  Matt Morris News  Matt Morris on Facebook
VP - Client Services
Laura Mantell
  Laura Mantell LinkedIn Profile  Laura Mantell Twitter Account  Laura Mantell News  Laura Mantell on Facebook
VP - Client Services
Haig Soghigian
  Haig Soghigian LinkedIn Profile  Haig Soghigian Twitter Account  Haig Soghigian News  Haig Soghigian on Facebook
VP - General Counsel
Dhara Sheth
  Dhara Sheth LinkedIn Profile  Dhara Sheth Twitter Account  Dhara Sheth News  Dhara Sheth on Facebook
VP - Human Resources
Jedd Lucas
  Jedd Lucas LinkedIn Profile  Jedd Lucas Twitter Account  Jedd Lucas News  Jedd Lucas on Facebook
VP - Marketing
Kim Baker
  Kim Baker LinkedIn Profile  Kim Baker Twitter Account  Kim Baker News  Kim Baker on Facebook
VP - Operations
Daniel Wang
  Daniel Wang LinkedIn Profile  Daniel Wang Twitter Account  Daniel Wang News  Daniel Wang on Facebook
VP - Product Management
Michael Fives
  Michael Fives LinkedIn Profile  Michael Fives Twitter Account  Michael Fives News  Michael Fives on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/27/2022: Walnut venture capital transaction
Next: 1/27/2022: Botanical Solutions venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2026. Gaebler Ventures. All rights reserved.